__NUXT_JSONP__("/drugs/Daunorubicin_Hydrochloride", (function(a,b,c,d,e){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[{brand:a,indication:"INDICATIONS AND USAGE Daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.",manufacturer:"Hikma Pharmaceuticals USA Inc.",splSetId:"227784a8-ce68-4dd4-8ac5-a65265969677"},{brand:c,indication:d,manufacturer:"Teva Parenteral Medicines, Inc.",splSetId:"29fe455e-f177-4b0e-99fb-60a53016db72"},{brand:a,indication:d,manufacturer:"Hisun Pharmaceuticals USA, Inc.",splSetId:"9705fa12-499e-41a3-8fb4-f6df0858b851"}],id:b,nciThesaurus:{casRegistry:"23541-50-6",chebiId:"",chemicalFormula:"C27H29NO10.HCl",definition:"The hydrochloride salt of an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.  Daunorubicin exhibits cytotoxic activity through topoisomerase-mediated interaction with DNA, thereby inhibiting DNA replication and repair and RNA and protein synthesis.",fdaUniiCode:"UD984I04LZ",identifier:"C1583",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C1594"],synonyms:["5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride","5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-(9CI)","CERUBIDINE","Cerubidin","Cerubidine","Cloridrato de Daunorubicina","DAUNORUBICIN HYDROCHLORIDE","Daunoblastin","Daunoblastina","Daunoblastine","Daunomycin Hydrochloride","Daunomycin hydrochloride","Daunomycin, hydrochloride",a,"Daunorubicin hydrochloride","Daunorubicin.HCl","Daunorubicini Hydrochloridum","FI-6339","L-lyxo-Hexopyranoside, 3beta-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-metldioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-,alpha-,hydrochloride","Ondena","RP-13057","Rubidomycin Hydrochloride","Rubilem","daunomycin hydrochloride",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FDaunorubicin_Hydrochloride",extension:".json",createdAt:e,updatedAt:e}}],fetch:{},mutations:void 0}}("Daunorubicin Hydrochloride","Daunorubicin_Hydrochloride","daunorubicin hydrochloride","INDICATIONS AND USAGE Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.","2021-10-30T13:34:46.763Z")));